A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers

Inclusion Criteria: * Healthy male and female volunteers, 18 to 55 years of age, inclusive Healthy status as defined by absence of evidence of any active or chronic disease following a detailed medical and surgical history and a complete physical examination * Japanese subjects must have Japanese parents and grandparents who were born in Japan * Caucasian subjects must have Caucasian parents and grandparents * Body mass index (BMI) 18 - 30 kg/m2 inclusive Exclusion Criteria: * Clinically significant abnormalities in laboratory test results (including positive test for HIV, hepatitis B and/or C), vital signs or ECGs * Any confirmed significant allergic reactions against any drug, or multiple allergies (non-active hay fever is acceptable) * Smokes more than 5 cigarettes per day during the three months prior to study conduct * Participation in an investigational drug or device study within 30 days or 5 half-lives prior to screening * Positive test for drugs of abuse * Any suspicion of or history of alcohol and/or other substance abuse or addiction * Pregnant or lactating women